Myelodysplastic Syndrome Post Cytotoxic Therapy

Myelodysplastic Syndrome Post Cytotoxic Therapy — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: Andrew E. Place, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02658487	Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia(VITAL)	completed	Phase 2	42	Vanderbilt-Ingram Cancer CenterOTHER	1	Apr 15, 2025	clinicaltrials
NCT01823198	Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies	completed	Phase 1 / Phase 2	63	M.D. Anderson Cancer CenterOTHER	1	Nov 7, 2023